Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1831 2
1840 1
1889 1
1912 1
1913 1
1917 1
1940 1
1941 1
1947 1
1948 1
1950 6
1951 1
1952 2
1953 1
1954 1
1955 1
1957 2
1958 6
1959 2
1960 3
1961 2
1962 3
1963 2
1964 3
1965 6
1966 2
1967 5
1968 5
1969 2
1970 2
1971 7
1972 6
1973 3
1974 6
1975 3
1976 5
1977 8
1978 1
1979 6
1980 5
1981 5
1982 7
1983 3
1984 4
1985 2
1986 3
1987 2
1988 5
1989 6
1990 6
1991 4
1992 5
1993 3
1994 1
1995 5
1996 1
1997 3
1998 3
1999 3
2000 1
2001 4
2002 8
2003 8
2004 10
2005 16
2006 22
2007 16
2008 26
2009 19
2010 22
2011 25
2012 36
2013 29
2014 26
2015 40
2016 39
2017 33
2018 47
2019 53
2020 51
2021 39
2022 48
2023 25
2024 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

772 results

Results by year

Filters applied: . Clear all
Page 1
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.
Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. Alikhan A, et al. Among authors: kimball ab. J Am Acad Dermatol. 2019 Jul;81(1):76-90. doi: 10.1016/j.jaad.2019.02.067. Epub 2019 Mar 11. J Am Acad Dermatol. 2019. PMID: 30872156 Free PMC article. Review.
Hidradenitis suppurativa.
Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Sabat R, et al. Among authors: kimball ab. Nat Rev Dis Primers. 2020 Mar 12;6(1):18. doi: 10.1038/s41572-020-0149-1. Nat Rev Dis Primers. 2020. PMID: 32165620 Review.
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Ruëff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Kimball AB, et al. Lancet. 2023 Mar 4;401(10378):747-761. doi: 10.1016/S0140-6736(23)00022-3. Epub 2023 Feb 3. Lancet. 2023. PMID: 36746171 Clinical Trial.
Psoriasis: is the impairment to a patient's life cumulative?
Kimball AB, Gieler U, Linder D, Sampogna F, Warren RB, Augustin M. Kimball AB, et al. J Eur Acad Dermatol Venereol. 2010 Sep;24(9):989-1004. doi: 10.1111/j.1468-3083.2010.03705.x. Epub 2010 May 7. J Eur Acad Dermatol Venereol. 2010. PMID: 20477920
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, Armstrong AW, Kerdel F, Gold MH, Forman SB, Korman NJ, Giamarellos-Bourboulis EJ, Crowley JJ, Lynde C, Reguiai Z, Prens EP, Alwawi E, Mostafa NM, Pinsky B, Sundaram M, Gu Y, Carlson DM, Jemec GB. Kimball AB, et al. N Engl J Med. 2016 Aug 4;375(5):422-34. doi: 10.1056/NEJMoa1504370. N Engl J Med. 2016. PMID: 27518661 Free article. Clinical Trial.
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study.
Kirby JS, Okun MM, Alavi A, Bechara FG, Zouboulis CC, Brown K, Santos LL, Wang A, Bibeau KB, Kimball AB, Porter ML. Kirby JS, et al. Among authors: kimball ab. J Am Acad Dermatol. 2024 Mar;90(3):521-529. doi: 10.1016/j.jaad.2023.10.034. Epub 2023 Oct 21. J Am Acad Dermatol. 2024. PMID: 37871805 Free article. Clinical Trial.
What causes hidradenitis suppurativa ?-15 years after.
Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos-Bourboulis EJ, Fabbrocini G, Frew JW, Fujita H, González-López MA, Guillem P, Gulliver WPF, Hamzavi I, Hayran Y, Hórvath B, Hüe S, Hunger RE, Ingram JR, Jemec GBE, Ju Q, Kimball AB, Kirby JS, Konstantinou MP, Lowes MA, MacLeod AS, Martorell A, Marzano AV, Matusiak Ł, Nassif A, Nikiphorou E, Nikolakis G, Nogueira da Costa A, Okun MM, Orenstein LAV, Pascual JC, Paus R, Perin B, Prens EP, Röhn TA, Szegedi A, Szepietowski JC, Tzellos T, Wang B, van der Zee HH. Zouboulis CC, et al. Among authors: kimball ab. Exp Dermatol. 2020 Dec;29(12):1154-1170. doi: 10.1111/exd.14214. Exp Dermatol. 2020. PMID: 33058306 Free article. Review.
Secukinumab in the treatment of hidradenitis suppurativa.
Snyder CL, Gibson RS, Porter ML, Kimball AB. Snyder CL, et al. Among authors: kimball ab. Immunotherapy. 2023 Dec;15(17):1449-1457. doi: 10.2217/imt-2023-0103. Epub 2023 Oct 16. Immunotherapy. 2023. PMID: 37840286 Review.
HIV and mpox: a rapid review.
O'Shea JG, Bonacci RA, Cholli P, Kimball A, Brooks JT. O'Shea JG, et al. Among authors: kimball a. AIDS. 2023 Nov 15;37(14):2105-2114. doi: 10.1097/QAD.0000000000003684. Epub 2023 Oct 26. AIDS. 2023. PMID: 37877274 Free PMC article. Review.
772 results